Latest Breaking News On - Geltex pharmaceuticals - Page 1 : vimarsana.com

Jim Tananbaum, Founder and CEO of Foresite Capital, Announces $173 Million in Funds Raised for Foresite Labs Incubated Companies

Jim Tananbaum, Founder and CEO of Foresite Capital, Announces $173 Million in Funds Raised for Foresite Labs Incubated Companies
lapostexaminer.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lapostexaminer.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoJim tananbaumVikram bajajTensixteen bioHarvard business schoolGeltex pharmaceuticalsForesite capital fundGoogle life sciencesForesite capitalForesite labsInterline therapeuticsSestina bioGoogle lifeApplied mathematicsElectrical engineering

Carmichael Roberts, Sean O Sullivan will share insights into climate tech and investing at Disrupt – TechCrunch

Carmichael Roberts, Sean O Sullivan will share insights into climate tech and investing at Disrupt – TechCrunch
techcrunch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from techcrunch.com Daily Mail and Mail on Sunday newspapers.

Sean osullivanCarmichael robertsUnion carbide corporationGeltex pharmaceuticalsBreakthrough energy venturesDow chemicalSeano sullivanTechcrunch disruptMaterial impactசீன் ஓசுள்ளிவண்கார்மைக்கேல் ராபர்ட்ஸ்தொழிற்சங்கம் கார்பைடு நிறுவனம்திருப்புமுனை ஆற்றல் முயற்சிகள்டோ இரசாயனபொருள் தாக்கம்

Chutes & Ladders—Another Novartis exec answers the biotech call, this time for gene therapy startup Tevard

Novartis has lost another NIBR exec to the call of biotech. Blueprint Medicines has added another BMS vet to its roster. And Iovance quietly announced its CEO's departure Wednesday.

United statesStephen bassoInozyme pharmaFraiser kansteinerEli lillyMann muhsinEverett croslandBradley gloverGopi shankerGary romanoGary baldwinRichard morrisSugandh sharmaTyler ralstonJohnson janssenAeglea biotherapeutics

BioSpace Movers & Shakers, May 21

Published: May 21, 2021 By Alex Keown Biopharma and life sciences companies strengthen their leadership teams and board with these Movers & Shakers. AavantiBio – Jessie Hanrahan was named chief regulatory officer of AavantiBio. Hanrahan will oversee global regulatory affairs for AavantiBio’s diversified pipeline of gene therapy programs targeting rare diseases with significant unmet medical needs. Most recently, she was Vice President of Regulatory Science at bluebird bio, Inc. Prior to bluebird bio, Hanrahan held positions of increasing responsibility at Genzyme Corp. where she worked across the oncology, multiple sclerosis and rare disease therapeutic areas. Earlier in her career, Hanrahan worked at Boston Scientific Corporation.

United statesStephen bassoInozyme pharmaPhelps mcnamaraR michael carruthersSynageva biopharmaPeter pechanSierk poettingJens hoslteinLucio tozziBradley gloverBristol myers squibbMark pennesiGuy levyEvelo biosciencesTyler ralston

Sagimet Biosciences Appoints Life Sciences Industry Veteran Elizabeth Grammer to Board of Directors

Sagimet Biosciences Appoints Life Sciences Industry Veteran Elizabeth Grammer to Board of Directors News provided by Share this article Share this article SAN MATEO, Calif., May 3, 2021 /PRNewswire/ Sagimet Biosciences, a clinical-stage biotechnology company focused on developing a portfolio of internally-discovered, selective fatty acid synthase (FASN) inhibitors, announced today the appointment of Elizabeth Grammer, Esq., to its board of directors. Ms. Grammer brings to her role as director over 25 years of experience advising privately held and publicly traded life sciences companies at all stages of development. George Kemble, Ph.D., Sagimet s chief executive officer, said, Elizabeth is a strategic and innovative thinker with a passion for developing, articulating and leading the execution of corporate strategy and will be a great addition to our board. We look forward to leveraging her extensive experience to help Sagimet grow our business.

Stanford universityUnited statesBoston universitySagimet biosciencesElizabeth grammerGeorge kembleCalifornia life sciences associationSagimet biosciences incGeltex pharmaceuticalsArdelyx incStanford university law schoolTrine pharmaceuticalsGenzyme corporationStanford university lawState barஸ்டான்போர்ட் பல்கலைக்கழகம்